Curanex Pharmaceuticals (CURX) vs Soligenix (SNGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Curanex Pharmaceuticals is the larger company by market cap ($8.3 million vs $7.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CURX | SNGX |
|---|---|---|
| Share price | $5.31 | $0.3636 |
| Market cap | $8.33M | $7.91M |
| 1-day change | +11.55% | +4.90% |
| EPS (TTM) | $-7.80 | $-0.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.94 | $1.80 |
| 52-week low | $3.58 | $0.28 |
| Distance from 52-week high | -68.65% | -79.80% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +279.54% |
| Average volume | 20.11K | 249.87K |
| Shares outstanding | 1.57M | 21.77M |
| Employees | 6 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Soligenix
SNGX stock →Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
CURX vs SNGX FAQ
Which is bigger, Curanex Pharmaceuticals or Soligenix?
Curanex Pharmaceuticals (CURX) is larger, with a market capitalization of $8.33M compared with $7.91M for Soligenix (SNGX).
Are Curanex Pharmaceuticals and Soligenix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.